KONEXMachinery232530

Energy Material Technology

₩10,280▼ 0.19%2026-10-02 close

Market Cap

₩263.3B

Turnover

₩6,620,610

Volume

643 shares

Shares out.

25.6M

PER

—

PBR

—

EPS

—

Dividend Yield

—

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-10-02 close

Report overview

NCM Precursor Maker Turns Profitable After Years of Losses

EMT achieved a landmark turnaround in FY2025, recording its first-ever operating and net profit alongside a 269.6% surge in revenues, marking the company's transition from chronic loss-maker to viable NCM precursor producer.

1
FY2025 revenue surged 269.6% YoY with operating and net profit both turning positive for the first time in company history
2
Proprietary waste-precursor recycling and metal dissolution processes are the primary drivers of improved cost structure and profitability
3
Annual NCM precursor capacity of 6,120 tons, with product line expansion underway toward high-nickel variants NCM424 and NCM622
4
KONEX market listing entails very limited trading liquidity; valuation pressure has increased following the sharp share price rally in 2026
5
Steady on-market purchases by major shareholder Jaeseneungwon and rising retail investor interest provide a degree of near-term demand support

Business structure

EMT's full name is Energy Material Technology, and its sole core business is the manufacture of precursor materials for lithium-ion battery cathodes.

Precursors are intermediate materials used in cathode manufacturing, and the company supplies NCM-series precursors to the electric vehicle (EV) and energy storage system (ESS) markets.

The company has been mass-producing NCM111 and NCM523 precursors since 2012 and is currently developing higher-nickel variants such as NCM424 and NCM622, a strategy that targets both higher energy density and improved cost competitiveness.

Annual production capacity stands at approximately 6,120 tons, with the Chungju facility as the sole manufacturing site.

The most notable technological differentiator is the company's proprietary waste-precursor recycling process combined with metal dissolution technology, which significantly reduces raw material costs (nickel, cobalt, manganese).

EMT also pursues eco-friendly manufacturing frameworks and metal coating technology development, holding both ISO 9001 and ISO 14001 certifications.

With approximately 91 employees, EMT is a compact specialist manufacturer — far smaller in absolute production scale than major cathode and precursor players such as EcoPro BM, Cosmo New Material, and L&F, but it competes via niche cost-reduction technology.

The high concentration in a single business segment means financial results are directly exposed to sector cycles and commodity price swings, while the KONEX listing limits institutional access and public disclosure obligations compared to KOSPI/KOSDAQ peers.

Recent trends

For FY2025 (standalone basis), EMT reported revenue growth of 269.6% YoY, with both operating profit and net profit turning positive for the first time, according to FnGuide data.

The improvement was driven by rising demand for NCM-series precursors and the application of the company's waste-precursor recycling technology, which meaningfully reduced manufacturing costs.

Looking at the prior-year results disclosed in April 2025, FY2024 revenue came in at approximately KRW 9.85 billion (+7.94% YoY), with gross profit finally turning positive at KRW ~0.93 billion versus a loss of KRW ~5.05 billion in the prior year.

However, FY2024 still registered an operating loss of approximately KRW -960 million (vs. KRW -6.64 billion in FY2023) and a net loss of around KRW -1.95 billion (vs. KRW -7.48 billion), indicating that FY2024 was a transitional year with sharply narrowing losses.

The landmark FY2025 profitability confirmation acted as a key catalyst for a significant stock re-rating in 2026. The share price stood near KRW 4,480 in early January 2026, rose to KRW 9,340 in early April 2026, and reached KRW 14,100 as of June 5, 2026 — roughly a 3x gain year-to-date.

Major shareholder Jaeseneungwon has been consistently accumulating shares through on-market purchases since late 2025, and a notable surge in retail investor buying was recorded around the time of the FY2024 results disclosure.

Nevertheless, the KONEX-specific daily trading volume of approximately KRW 100 million underscores persistent liquidity constraints, and the sharp price appreciation demands attention to potential valuation overshoot.

Outlook

Building on the FY2025 profitability inflection, EMT's medium-term growth trajectory is closely tied to the pace of global EV and ESS market expansion and the structural shift toward higher-nickel NCM cathodes.

Completion of NCM424 and NCM622 development could improve selling prices and margins, while advances in metal coating technology and eco-friendly process innovation serve as pillars of longer-term technical differentiation.

The waste-precursor recycling technology acts as a cost buffer against raw material price increases, making its further process-level scaling the most critical variable for margin sustainability.

However, Chinese precursor manufacturers continue to add large-scale capacity, and intensifying price competition remains a structural overhang. The KONEX listing's inherent liquidity constraints will continue to limit institutional and foreign investor access unless a transfer to KOSDAQ is pursued.

Overall, earnings momentum has become visible, but sustained verification of profitability and topline scale is needed before the medium-term investment thesis can be established with greater confidence.

Bull factors

Waste-Precursor Recycling: A Proprietary Cost Moat

EMT holds proprietary waste-precursor reuse and metal dissolution technologies that directly reduce input costs for nickel, cobalt, and manganese.

FnGuide explicitly cites these as the primary drivers behind the FY2025 profitability turnaround, and the technologies provide superior resilience against commodity price swings compared to peers lacking such processes.

Given the technical barriers involved, near-term replication by competitors is challenging, allowing the company to secure a defensible niche position despite its small scale.

Structural Demand Tailwind from EV and ESS Growth

As global EV and ESS markets expand structurally over the medium to long term, demand for NCM precursors — a critical battery material — is expected to grow in tandem.

EMT's NCM precursors are used directly in high-energy EV cells and large-scale ESS systems, and successful development of higher-nickel grades such as NCM622 could unlock further selling price improvements.

Domestic battery cell manufacturers' growing emphasis on localizing materials procurement also creates a gradual tailwind for domestic precursor specialists like EMT.

First-Ever Profit Triggers Fundamental Re-Rating

The FY2025 simultaneous turnaround in both operating and net profit was the first tangible validation of EMT's business model viability for market participants, directly catalyzing the share price re-rating.

The prior-year FY2024 results had already signaled a structural inflection — with gross profit turning positive at KRW ~930 million (vs. a loss of KRW ~5.05 billion) and operating losses narrowing sharply — confirming that the FY2025 profitability is the product of multi-year cost restructuring rather than a one-time event.

The sustained on-market purchases by major shareholder Jaeseneungwon and the surge in retail investor participation through 2026 further reflect growing market confidence in the company's fundamental recovery.

Bear factors

Chinese Capacity Expansion and Intensifying Price Competition

In the global NCM precursor market, large Chinese players such as Huayou Cobalt, CNGR, and BTR continue to add capacity aggressively, driving persistent downward pressure on precursor prices.

EMT's annual capacity of 6,120 tons is a fraction of these competitors', placing the company at a structural disadvantage on economies of scale.

While waste-precursor recycling technology provides a cost buffer, a prolonged market-wide price decline could erode the recently achieved profitability and interrupt the improvement trend.

KONEX Illiquidity and Price Discovery Distortions

The KONEX market's extremely thin daily trading volume of around KRW 100 million means that price movements risk being amplified disproportionately by supply-demand shocks rather than fundamental changes.

With institutional investor access limited and trading dominated by a small pool of retail participants, price discovery efficiency is low.

Given that the share price has more than tripled in a short period through 2026, the risk of a demand-driven price correction exists independently of whether earnings growth is sustained.

Single-Product Concentration and Revenue Volatility

EMT's business is concentrated in a single product — NCM precursors — making total revenues directly vulnerable to battery demand cycles and any changes in key customers' procurement strategies.

The prior transition from FY2023 to FY2024 saw gross losses in the multi-billion KRW range, illustrating how sharply results can swing.

Without meaningful business diversification, the company remains exposed to rapid earnings deterioration if precursor market conditions weaken or customer concentration increases further.

Risk factors

Raw Material Price Risk

Nickel, cobalt, and manganese — the primary raw materials for NCM precursors — exhibit significant price volatility in global commodity markets. Cobalt in particular carries high geopolitical supply concentration risk, and sharp price spikes could rapidly pressure EMT's manufacturing costs.

While the waste-precursor recycling technology provides a cost buffer, it may not fully offset sudden material price surges. The ability to pass cost increases through to customers will be the key determinant of margin protection in a rising raw material environment.

EV Demand Slowdown Risk

Global EV demand could enter short-term stagnation or inventory adjustment phases due to inadequate charging infrastructure, vehicle price sensitivity, and subsidy reductions in major markets.

A slowdown in EV sales would translate directly into lower battery cell production and reduced orders for cathode and precursor materials.

Given EMT's high single-segment dependency, the impact of a sector downturn would be more concentrated than for diversified peers — a risk previously illustrated by the sharp revenue decline and large losses recorded around 2020.

KONEX Listing and Disclosure Risk

The KONEX market imposes less stringent disclosure obligations and corporate governance requirements than KOSPI or KOSDAQ, resulting in relatively greater information asymmetry risk for investors.

The absence of mandatory quarterly earnings disclosures makes it difficult to track intra-year financial trends and limits the quality of information available to market participants.

Additionally, the low liquidity environment means that any large sell-off could cause disproportionate price dislocations, and a persistent valuation discount is likely unless the company pursues and completes a market transfer to KOSDAQ.

Overall view

EMT delivered its first-ever annual profit in FY2025, providing the initial proof of concept for its business model, accompanied by an exceptional 269.6% revenue surge.

The company's proprietary waste-precursor recycling cost advantage and plans to expand into higher-nickel grades underpin a coherent medium-term growth narrative.

However, the share price has already more than tripled year-to-date through 2026, suggesting that the profitability re-rating has been substantially priced in. The extremely low daily KONEX trading volume of approximately KRW 100 million simultaneously undermines price discovery reliability and practical tradability.

Structural risks — including competition from large Chinese precursor manufacturers, commodity price volatility, and high single-product revenue concentration — remain unresolved.

At this stage, a measured monitoring approach focused on the sustainability of FY2025 profitability, the timeline for mass production of higher-nickel precursors, and any progress on a potential KOSDAQ transfer is the most prudent analytical stance.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 7 more articles and sources

Report written 2026-06-05 · Data as of 2026-06-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.